EU MDR Change Impact Assessment for Medical Devices
Assess proposed device changes with a structured EU MDR lens before they disrupt CE marking, trigger unnecessary Notified Body involvement, or create compliance exposure. Elexes helps manufacturers evaluate design, software, labeling, material, and process changes against Article 120 and MDCG guidance, producing a documented, defensible rationale that supports continuity, audit readiness, and smarter regulatory decisions.
Our Change Impact Assessment Services
Focused regulatory support for evaluating, documenting, and defending medical device changes under EU MDR requirements.
EU MDR Change Assessment
Structured evaluation of design, software, material, manufacturing, sterilization, labeling, or intended purpose changes to determine significance under EU MDR and applicable MDCG guidance.
EU MDR Gap Assessment
Detailed benchmarking of existing documentation, clinical evidence, PMS systems, and quality processes against EU MDR requirements to identify gaps that may affect change implementation.
Technical Documentation Support
Hands-on support to update Annex II and III technical documentation, GSPR evidence, risk files, and related records so change decisions remain traceable and defensible.
Submission Readiness Review
Expert readiness assessment for manufacturers preparing for Notified Body engagement after a significant change, with prioritized actions to reduce review delays and deficiencies.
Risk Management Alignment
Review and strengthen ISO 14971-aligned risk management documentation so change impacts on safety, performance, and benefit-risk are clearly assessed and cross-referenced.
Labeling IFU Compliance
Assessment of labeling and IFU updates against EU MDR Annex I requirements to confirm revised claims, symbols, language, and UDI-related elements remain compliant.
Documented Regulatory Clarity
Defensible Change Decisions Under EU MDR
When a CE-marked medical device changes, the regulatory impact must be evaluated before implementation—not after an audit finding or Notified Body challenge. Elexes delivers a structured assessment that examines the nature of the change, its effect on safety and performance, and whether it may qualify as significant under EU MDR. The result is a clear, documented rationale your team can use to support compliant decisions, preserve market continuity, and strengthen change control governance.
Trusted By Manufacturers
Client Outcomes
Supporting medical device teams with clearer regulatory decisions, stronger documentation, and more confident change control execution.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for rigorous, practical regulatory support across complex device lifecycles.
Deep Expertise
50+ years of collective experience across EU MDR, FDA, ISO 13485, and global device frameworks.
Defensible Documentation
Assessments are fully documented to support audits, Notified Body reviews, and internal change control decisions.
End-to-End Support
From gap analysis to remediation, Elexes supports the full compliance path after change evaluation.
Proven Track Record
250+ successful projects across 200+ product types with a 90% audit clearance rate.
Meet The Elexes Team
Experienced regulatory specialists for complex device changes.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with specialized regulatory and quality consulting across the full product lifecycle. The company has built its reputation by helping organizations navigate demanding frameworks such as EU MDR, FDA, TGA, and other global requirements with disciplined, evidence-based support. Backed by 50+ years of collective experience, the Elexes team works across technical documentation, risk management, submission readiness, post-market obligations, and change governance. With 250+ successful projects completed across 200+ product types and support delivered to clients in the USA, UK, Europe, Canada, Australia, and Asia, Elexes focuses on practical regulatory execution that protects market access, reduces avoidable delays, and gives manufacturers a clearer path through complex compliance decisions.
50+ YearsCollective regulatory and compliance experience250+ ProjectsSuccessful engagements delivered across device programs200+ Product TypesBroad experience across diverse medical technologies
Frequently Asked Questions
What is the purpose of the change impact assessment?
The purpose of a change impact assessment is to determine whether a proposed or implemented device change affects the product’s regulatory status, safety, performance, or conformity assessment basis. Under EU MDR, it helps manufacturers decide whether the change is significant, whether Notified Body involvement is needed, and what documentation updates are required. It also creates an auditable rationale for change control decisions.
What is a significant change under MDR?
A significant change under MDR is a modification that may affect the device’s intended purpose, design, performance, safety, or the conditions under which conformity was originally assessed. Examples can include major software changes, material changes, manufacturing process changes, or labeling revisions that alter claims. The determination must be made against EU MDR requirements and relevant MDCG guidance, not by assumption alone.
What types of device changes should be assessed under EU MDR?
Manufacturers should assess changes to design, raw materials, components, software, sterilization methods, manufacturing processes, suppliers, labeling, IFU content, packaging, and intended purpose. Even changes that seem operational or administrative can affect compliance if they alter safety, performance, traceability, or the basis of the original CE marking. A structured assessment helps separate low-risk updates from changes requiring deeper regulatory action.
Does every change require Notified Body involvement?
No, not every change requires Notified Body involvement. Many updates can be managed within the manufacturer’s quality system if they do not materially affect safety, performance, intended purpose, or the conformity assessment basis. The key is documenting why the change is or is not significant under EU MDR and MDCG guidance. A formal assessment helps avoid both under-reporting and unnecessary escalation.
What documents are reviewed during an EU MDR change impact assessment?
Typical inputs include the change request, design documentation, risk management file, clinical evaluation materials, technical documentation, labeling and IFU content, verification and validation records, PMS data, and prior conformity assessment records. Reviewing these together allows the assessor to understand the full regulatory effect of the change and identify any linked updates needed across the technical file.
How does change impact assessment support audit readiness?
A documented assessment shows auditors and Notified Bodies that your organization evaluates changes systematically before implementation. It demonstrates that decisions were based on regulatory criteria, supported by evidence, and integrated into change control. This reduces the risk of findings related to undocumented rationale, incomplete technical documentation updates, or changes introduced without proper review of safety, performance, and conformity implications.
Can software changes to a medical device trigger a significant change determination?
Yes, software changes can trigger a significant change determination, especially when they affect functionality, intended use, clinical performance, cybersecurity posture, algorithms, user interface logic tied to safety, or interoperability. Even updates presented as maintenance releases may require review if they influence risk controls or performance claims. Software modifications should always be assessed against the device’s approved configuration and supporting evidence.
What deliverable should a manufacturer expect from this service?
A manufacturer should expect a structured, written assessment that defines the change, identifies the applicable regulatory framework, evaluates impact on safety and performance, and states whether the change is considered significant under EU MDR. Strong deliverables also include the rationale, referenced guidance, affected documentation, and recommended next steps such as technical file updates, remediation actions, or Notified Body engagement.
Need Clarity On A Device Change?
Speak with regulatory experts for a documented EU MDR assessment.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance capability
